ScholarIQanswers from OpenAlex

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

PaperCitations, authors & open-access status

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III have?

ScholarIQcitation count

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III has 235 citations in the OpenAlex counts ScholarIQ stores.

When was Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III published?

ScholarIQyear

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III has 2009 year in the ScholarIQ index.

What is the open-access status of Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III?

ScholarIQoa status

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III has green oa status in the ScholarIQ index.

What is the DOI of Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III?

ScholarIQdoi

The DOI for Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III is on the source record.

What is the PMID of Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III?

ScholarIQpmid

The PMID for Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III is on the source record.

What is the OpenAlex record for Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III?

ScholarIQopenalex

The OpenAlex for Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial